FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385055001: Tablet (basic dose form)

  • SNOMED CT Concept\Qualifier value\Basic dose form (basic dose form)\Solid dose form\A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition.

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
1459233010 Tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1479317011 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2536656014 Tablets en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2613089014 Tablet dose form (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2660323018 Tablet dose form (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2770896013 Tablet dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3534602016 Tablet (basic dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3635452013 A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. en Definition Active Entire term case sensitive (core metadata concept) SNOMED CT core
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
13111000188116 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Type of drug preparation false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Oral dose form false Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Is a Solid dose form true Inferred relationship Existential restriction modifier (core metadata concept)
A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Has state of matter (attribute) Solid (state of matter) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Amylase + lipase + protease 30000unt/8000unt/30000unt tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amylase + lipase + protease 6000unt/16000unt/6000unt tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + carisoprodol + codeine phosphate 325mg/200mg/16mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and carisoprodol 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 500 mg and hydrocodone bitartrate 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and meprobamate 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and methocarbamol 400 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and oxycodone hydrochloride 2.25 mg and oxycodone terephthalate 190 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and oxycodone hydrochloride 4.5 mg and oxycodone terephthalate 380 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + pentazocine hydrochloride 325mg/ns tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Atenolol + chlorthalidone 100mg/25mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Atenolol 50 mg and chlortalidone 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atovaquone 62.5 milligram and proguanil 25 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atropine 25 microgram and difenoxin hydrochloride 1 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Azatadine maleate + pseudoephedrine sulphate 1mg/120mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Benazepril hydrochloride 10 mg and hydrochlorothiazide 12.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Candesartan cilexetil + hydrochlorothiazide 16mg/12.5mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Captopril 25 mg and hydrochlorothiazide 15 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely captopril 25 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Captopril 50 mg and hydrochlorothiazide 15 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Carbidopa + levodopa 50mg/200mg m/r tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbidopa 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Chlorothiazide 250 mg and methyldopa 250 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely chlorothiazide 250 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Chlorothiazide 500 mg and reserpine 125 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Chlorpheniramine maleate + methscopolamine nitrate + pseudoephedrine hydrochlorid 8mg/2.5mg/120mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Chlorthalidone + clonidine hydrochloride 15mg/0.3mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Choline bitartrate 25 mg and dexpanthenol 50 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely clemastine 1.34 milligram and phenylpropanolamine 75 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dehydrocholic acid 180 milligram and pancreatin 300 milligram and simeticone 40 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely deserpidine 250 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel + ethinyl estradiol + ethinyl oestradiol 0.15mg/0.01mg/0.01mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel + ethinyl oestradiol 0.15mg/0.03mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diltiazem maleate 219 milligram and enalapril maleate 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Diprophylline 200 mg and guaifenesin 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
énalapril 10 mg et hydrochlorothiazide 25 mg, comprimé oral Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
énalapril 5 mg et hydrochlorothiazide 12,5 mg, comprimé oral Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol + estradiol + norgestimate 1mg/1mg/0.09mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Oestradiol + norethindrone acetate 1mg/0.5mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely esterified estrogen 625 microgram and methyltestosterone 1.25 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Esterified estrogen 1.25 mg and methyltestosterone 2.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and etynodiol diacetate 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl oestradiol + ethynodiol diacetate 50mcg/1mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + ferrous fumarate + norgestrel 0.03mg/75mg/0.3mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 20 microgram and levonorgestrel 100 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 30 microgram and levonorgestrel 50 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + levonorgestrel 0.03mg/0.15mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 40 microgram and levonorgestrel 75 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl oestradiol + levonorgestrel 0.05mg/0.25mg pills Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only ethinyl estradiol 0.035 mg and norethisterone 0.5 mg/1 each oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ethinylestradiol 35 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 50 microgram and norethisterone 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl oestradiol + norethindrone acetate 20mcg/1mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + norethindrone acetate 30mcg/1.5mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + norgestimate 0.035mg/0.25mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ethinyl estradiol + norgestrel 0.05mg/0.5mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Ferrous fumarate 324 mg and folic acid 1 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Homatropine methylbromide 1.5 mg and hydrocodone bitartrate 5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and labetalol hydrochloride 300 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and lisinopril 20 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 15 mg and methyldopa 250 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and methyldopa 250 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 30 mg and methyldopa 500 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 50 mg and methyldopa 500 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and propranolol hydrochloride 40 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide + quinapril hydrochloride 12.5mg/10mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 12.5 milligram and quinapril 20 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 25 milligram and quinapril 20 milligram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and reserpine 125 microgram oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely hydrochlorothiazide 50 milligram and reserpine 125 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and spironolactone 25 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide+telmisartan 12.5mg/40mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 25 mg and triamterene 37.5 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrochlorothiazide 12.5 mg and valsartan 80 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Hydrocodone bitartrate 7.5 mg and ibuprofen 200 mg oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Isoniazid + pyrazinamide + rifampin 50mg/300mg/120mg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Levothyroxine sodium + liothyronine sodium 100mcg/25mcg tablet Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely levothyroxine sodium 12.5 microgram and liothyronine sodium 3.1 microgram/1 each conventional release oral tablet (clinical drug) Has manufactured dose form False A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 24 of 28 Next End

This concept is not in any reference sets

Back to Start